SCHEMBL7125353

SCHEMBL7125353

CCc1ccc(-c2csc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.59
MAPT P10636 6/20 0.58
GFER P55789 1/20 0.58
PPARG P37231 3/20 0.58
CYP2C8 P10632 1/20 0.58
POLB P06746 2/20 0.55
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 2/20 0.53
SLC2A1 P11166 1/20 0.53
RORC P51449 1/20 0.53
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
NPC1 O15118 1/20 0.52
CASP3 P42574 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128929 0.91 RAB9A (0.67) RAB9AMAPTGFERPPARGPOLB
SCHEMBL7120002 0.87 RAB9A (0.66) RAB9AMAPTGFERPPARGPOLB
SCHEMBL7125386 0.87 RAB9A (0.59) RAB9AMAPTGFERPPARGPOLB
SCHEMBL7128794 0.87 MEN1 (0.69) RAB9AMAPTPPARGPOLBMEN1
SCHEMBL7127621 0.87 ABL1 (0.63) RAB9AMAPTPOLBMEN1KMT2A
SCHEMBL7130746 0.85 RAB9A (0.69) RAB9AMAPTPPARGPOLBMEN1
SCHEMBL7129934 0.84 RAB9A (0.56) RAB9AMAPTGFERPPARGPOLB
SCHEMBL7130345 0.84 MEN1 (0.73) RAB9AMAPTPOLBMEN1KMT2A
SCHEMBL19435568 0.83 RAB9A (0.61) RAB9AMAPTPPARGPOLBMEN1
SCHEMBL7120737 0.83 MAPT (0.68) RAB9AMAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RAB9A 1179/4885MAPT 4391/4885GFER 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.